Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B

October 9, 2023

Bristol-Myers Squibb to acquire Mirati Therapeutics for .8B

Drew Angerer/Getty Images News Bristol-Myers Squibb (NYSE:BMY) agreed to purchase cancer drug maker Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. Bristol-Myers (BMY) agreed to acquire

Tag: Squibb

Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B